Effect modification of aortic atheroma on the prognostic value of heart rate in hypertension

被引:11
作者
Courand, Pierre-Yves [1 ,2 ,3 ]
Milon, Hugues [1 ,2 ,3 ]
Gustin, Marie-Paule [2 ,3 ]
Froment, Alain
Bricca, Giampiero [2 ,3 ]
Lantelme, Pierre [1 ,2 ,3 ,4 ]
机构
[1] Hosp Civils Lyon, Hop Croix Rousse, European Soc Hypertens Excellence Ctr, Dept Cardiol, Lyon, France
[2] Univ Lyon 1, F-69622 Villeurbanne, France
[3] Hop Nord Ouest, Villefranche, France
[4] Hop Nord Ouest, Dept Cardiol, Villefranche, France
关键词
arterial stiffness; cardiovascular death; heart rate; hypertension; target organ damage; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR EVENTS; ANTIHYPERTENSIVE TREATMENT; PREDICTIVE VALUE; PULSE PRESSURE; RISK-FACTOR; MORTALITY; OUTCOMES; PREVENTION; STIFFNESS;
D O I
10.1097/HJH.0b013e32835c44bb
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Although some epidemiological studies have advocated a prognostic value of heart rate (HR) in hypertensive patients, the influence of vascular damages on this prognostic value has not been tested yet. Methods: HRs were collected by pulse palpation in 1204 primary hypertensive patients in sinus rhythm without cardiac-slowing drugs. Aortic damages were assessed by aortography, whereas cardiac disease was assessed by medical history, symptoms and electrocardiogram. Results: In a multivariable Cox model adjusted for major confounders, HR was of prognostic significance for all-cause [hazard ratio 1.12 (1.06-1.19) for 10bpm increment and 1.39 (1.18-1.64) for HR >= 82 vs. <82 bpm] and cardiovascular death [hazard ratio 1.10 (1.02-1.20) for 10bpm increment and 1.37 (1.09-1.72) for HR >= 82 vs. <82 bpm] after 35 years of follow-up. This association was particularly manifested at 15 years of follow-up. At that time, with the same multivariable survival model, the association between HR and cardiovascular death was stronger in patients with aortic atheroma [2.76 (1.47-5.18) for an HR >= 82 vs. <82 bpm] than in patients without [hazard ratio 1.36 (0.76-2.43) for an HR >= 82 vs. <82 bpm, P for interaction = 0.054]. Similarly, the association between HR and cardiovascular death was stronger in patients with an overt cardiac disease than those without (P for interaction = 0.044). Conclusion: In hypertensive patients, the prognostic significance of HR for cardiovascular outcome is modulated by the presence of aortic atherosclerosis or cardiac disease. This should prompt us to a thorough examination of cardiovascular damages in hypertensive patients when HR is elevated.
引用
收藏
页码:484 / 491
页数:8
相关论文
共 35 条
[1]   Relation of Beta-Blocker-Induced Heart Rate Lowering and Cardioprotection in Hypertension [J].
Bangalore, Sripal ;
Sawhney, Sabrina ;
Messerli, Franz H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (18) :1482-1489
[2]   The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative [J].
Bangalore, Sripal ;
Messerli, Franz H. ;
Ou, Fang-Shu ;
Tamis-Holland, Jacqueline ;
Palazzo, Angela ;
Roe, Matthew T. ;
Hong, Mun K. ;
Peterson, Eric D. .
EUROPEAN HEART JOURNAL, 2010, 31 (05) :552-560
[3]   Influence of heart rate on mortality in a French population - Role of age, gender, and blood pressure [J].
Benetos, A ;
Rudnichi, A ;
Thomas, F ;
Safar, M ;
Guize, L .
HYPERTENSION, 1999, 33 (01) :44-52
[4]   Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period [J].
Benetos, A ;
Adamopoulos, C ;
Bureau, JM ;
Temmar, M ;
Labat, C ;
Bean, K ;
Thomas, F ;
Pannier, B ;
Asmar, R ;
Zureik, M ;
Safar, M ;
Guize, L .
CIRCULATION, 2002, 105 (10) :1202-1207
[5]  
Böhm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7
[6]   Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial [J].
Dahlöf, B ;
Sever, PS ;
Poulter, NR ;
Wedel, H ;
Beevers, DG ;
Caulfield, M ;
Collins, R ;
Kjeldsen, SE ;
Kristinsson, A ;
McInnes, GT ;
Mehlsen, J ;
Nieminen, M ;
O'Brien, E ;
Östergren, J .
LANCET, 2005, 366 (9489) :895-906
[7]   Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease [J].
Diaz, A ;
Bourassa, MG ;
Guertin, MC ;
Tardif, JC .
EUROPEAN HEART JOURNAL, 2005, 26 (10) :967-974
[8]   THE PREDICTIVE VALUE OF ADMISSION HEART-RATE ON MORTALITY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION [J].
DISEGNI, E ;
GOLDBOURT, U ;
REICHERREISS, H ;
KAPLINSKY, E ;
ZION, M ;
BOYKO, V ;
BEHAR, S ;
NEUFELD, HN ;
AGMON, J ;
ABINADER, E ;
FRIEDMAN, Y ;
HAMMERMAN, H ;
KAULI, N ;
KISHON, Y ;
MANDELZWEIG, L ;
PALANT, A ;
PELLED, B ;
RABINOWITZ, B ;
REISIN, L ;
RISS, E ;
ROSENFELD, T ;
SCHLESINGER, Z ;
SCLAROVSKY, S ;
ZAHAVI, I .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1995, 48 (10) :1197-1205
[9]  
DYER AR, 1980, AM J EPIDEMIOL, V112, P736, DOI 10.1093/oxfordjournals.aje.a113046
[10]   Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial [J].
Fox, Kim ;
Ford, Ian ;
Steg, P. Gabriel ;
Tendera, Michal ;
Robertson, Michele ;
Ferrari, Roberto .
LANCET, 2008, 372 (9641) :817-821